Loading...
Loading...
Comprehensive Guide
Melatonin is far more than a sleep supplement. It is the body's master chronobiotic hormone — signaling darkness to every cell, orchestrating circadian rhythms, scavenging free radicals, modulating immunity, and protecting neurons. Here is everything the science says about how it works, how to dose it, and how to optimize your own production naturally.
5
Biosynthesis steps
8
Natural boosters
7
Dosing protocols
10
FAQ answers
The Pathway
Melatonin is synthesized in five enzymatic steps from a single dietary amino acid. Understanding this pathway reveals every leverage point for optimization.
An essential amino acid obtained exclusively from diet. Found in turkey, chicken, eggs, dairy, nuts, seeds, and soy. Tryptophan crosses the blood-brain barrier via the large neutral amino acid transporter (LAT1), competing with other large neutral amino acids (BCAAs). This is why a high-carbohydrate meal can increase brain tryptophan availability: insulin drives competing amino acids into muscle, clearing the path for tryptophan uptake into the brain.
Next Enzyme
Tryptophan Hydroxylase (TPH)
Cofactors
Tetrahydrobiopterin (BH4), Iron, O2
The immediate precursor to serotonin. This is the rate-limiting step in the pathway — tryptophan hydroxylase activity determines how much serotonin (and ultimately melatonin) can be produced. 5-HTP is available as a supplement and bypasses the rate-limiting enzyme, but supplementing 5-HTP directly can cause peripheral serotonin accumulation and potential cardiac valve issues with long-term use. Short-term use (under 12 weeks) at 50-100mg may support melatonin production.
Next Enzyme
Aromatic L-Amino Acid Decarboxylase (AADC)
Cofactors
Pyridoxal Phosphate (Vitamin B6)
The immediate precursor to melatonin. Approximately 90% of the body's serotonin is produced in the gut (enterochromaffin cells), but this peripheral serotonin cannot cross the blood-brain barrier. The serotonin that becomes melatonin is synthesized locally in the pineal gland from tryptophan that has entered the brain. Serotonin production in the pineal gland peaks during daylight hours, building up the substrate pool that will be converted to melatonin after dark.
Next Enzyme
Arylalkylamine N-Acetyltransferase (AANAT)
Cofactors
Acetyl-CoA
The penultimate step. AANAT is the rate-limiting enzyme for melatonin synthesis and is under direct circadian control by the suprachiasmatic nucleus (SCN). AANAT activity increases 50-100 fold at night in the pineal gland, triggered by the release of norepinephrine from sympathetic neurons when the SCN detects darkness. Light exposure at night rapidly degrades AANAT, which is why even brief bright light exposure can suppress melatonin production within minutes.
Next Enzyme
Hydroxyindole-O-Methyltransferase (HIOMT)
Cofactors
S-Adenosylmethionine (SAMe)
The final product. Melatonin is not stored in the pineal gland — it is released immediately into the bloodstream and cerebrospinal fluid upon synthesis. Peak plasma concentrations occur between 2:00 and 4:00 AM in most adults, reaching 60-200 pg/mL (compared to daytime levels of 10-20 pg/mL). Melatonin is lipophilic and crosses all biological membranes, including the blood-brain barrier, allowing it to act on virtually every cell in the body.
Every step in this pathway has cofactor requirements: iron, BH4, vitamin B6, acetyl-CoA, and SAMe. Deficiencies in any of these nutrients — particularly B6 and magnesium — can bottleneck melatonin production regardless of tryptophan availability. This is why a nutrient-dense diet is foundational to melatonin optimization, not supplementation.
Signal Transduction
Melatonin exerts its effects through multiple receptor types, each mediating distinct physiological functions.
Location
SCN, pars tuberalis, retina, hippocampus, cerebral cortex, blood vessels
Function
Primarily mediates the acute sleep-promoting effects of melatonin. Activation of MT1 receptors in the SCN inhibits neuronal firing, reducing the alerting signal and promoting sleepiness. MT1 receptors in blood vessels cause vasoconstriction (which may contribute to the body temperature drop that facilitates sleep onset). MT1 activation also suppresses cAMP production, reducing cellular metabolic activity.
Location
SCN, retina, hippocampus, immune cells, bone, ovaries, testes
Function
Primarily mediates the circadian phase-shifting effects of melatonin. MT2 receptors in the SCN allow exogenous melatonin to reset the master clock — this is the mechanism behind melatonin's jet lag benefits. MT2 activation also modulates retinal dopamine release (relevant to eye health), influences bone metabolism, and plays a role in glucose homeostasis. Polymorphisms in MTNR1B are associated with increased risk of type 2 diabetes.
Location
Liver, kidney, heart, brain, intestine
Function
Initially identified as a melatonin binding site, MT3 is actually the enzyme quinone reductase 2 (NQO2). Melatonin binding to NQO2 inhibits the enzyme, which may contribute to melatonin's antioxidant and anti-cancer properties by modulating reactive oxygen species detoxification pathways. This site is less well characterized than MT1 and MT2 but is increasingly studied in oncology research.
Location
Widespread — immune cells, brain, liver, skin
Function
Retinoic acid-related orphan receptors that bind melatonin intracellularly. These nuclear receptors regulate gene transcription, making melatonin a true hormone with genomic effects. ROR receptors mediate melatonin's immune-modulatory functions, including regulation of T-cell differentiation, cytokine production, and inflammatory gene expression. This is why melatonin has broad anti-inflammatory and immunomodulatory effects beyond sleep.
Circadian Science
Understanding DLMO — the gold-standard biomarker of circadian phase — is essential for timing melatonin correctly.
The suprachiasmatic nucleus (SCN) in the hypothalamus is the master circadian pacemaker. It receives direct light input from melanopsin-containing retinal ganglion cells (ipRGCs) via the retinohypothalamic tract. During daylight, the SCN actively inhibits the pineal gland via a multisynaptic pathway through the paraventricular nucleus (PVN) and superior cervical ganglion (SCG). When the SCN detects darkness (absence of light input), it releases the inhibition: sympathetic neurons from the SCG release norepinephrine onto pineal cells, activating beta-1 adrenergic receptors, which triggers the 50-100 fold increase in AANAT enzyme activity that drives melatonin synthesis.
This is why even brief bright light exposure at night (checking your phone, turning on a bathroom light) can acutely suppress melatonin production within 5-10 minutes — light rapidly reactivates the SCN's inhibitory signal, degrading AANAT and halting synthesis. The sensitivity is wavelength-dependent: blue/green light (460-530nm) is maximally suppressive; red light (>620nm) has virtually no suppressive effect.
Dim Light Melatonin Onset (DLMO) is the time at which melatonin concentration in saliva or plasma rises above a threshold value under dim light conditions (<30 lux). DLMO typically occurs 2-3 hours before habitual sleep onset in entrained individuals. For someone who normally falls asleep at 11:00 PM, DLMO occurs around 8:00-9:00 PM.
DLMO is considered the most reliable biomarker of central circadian phase in both clinical and research settings. It is more accurate than actigraphy, sleep diaries, or core body temperature for determining the timing of your internal clock. DLMO timing determines:
Melatonin's clock-shifting effects depend on when it is taken relative to your DLMO and core body temperature minimum (Tmin, approximately 4-5 AM):
Phase Advance (Earlier)
Melatonin taken in the late afternoon or early evening (5-7 hours before DLMO) advances the circadian clock — shifting your entire cycle earlier. This is the mechanism used for jet lag after eastward travel and for treating Delayed Sleep Phase Syndrome. The advance zone peaks at approximately 5 hours before habitual DLMO.
Phase Delay (Later)
Melatonin taken in the late night or early morning (after the core body temperature minimum, typically after 5 AM) delays the circadian clock — shifting the cycle later. This is occasionally used for Advanced Sleep Phase Syndrome (falling asleep too early). Most people do not need phase delay and should avoid morning melatonin.
Want This Personalized?
This guide gives you the science. A CryoCove coach gives you the personalization — the right dose, timing, and integration with your other 8 pillars.
Evidence-Based Dosing
Less is more. Physiological doses (0.3-1mg) are often as effective or more effective than the supraphysiological doses (5-10mg) sold in most stores.
| Indication | Dose | Timing | Form | Tier |
|---|---|---|---|---|
| Sleep Onset (General) | 0.3 - 0.5 mg | 30-60 minutes before desired bedtime | Immediate release (sublingual or tablet) | Tier A |
| Sleep Maintenance (Night Waking) | 1 - 2 mg | 30-60 minutes before bed | Extended / sustained release | Tier A |
| Jet Lag (Eastward Travel) | 0.5 - 1 mg | At target destination bedtime for 3-5 nights | Immediate release | Tier A |
| Jet Lag (Westward Travel) | 0.5 mg | Second half of the night if you wake early | Immediate release | Tier B |
| Shift Work | 0.5 - 3 mg | 30-60 minutes before desired daytime sleep | Extended release preferred | Tier A |
| Delayed Sleep Phase Syndrome (DSPS) | 0.5 - 1 mg | 5-7 hours before current sleep onset (NOT at bedtime) | Immediate release | Tier A |
| Antioxidant / Anti-Inflammatory | 3 - 10 mg | Before bed | Immediate or extended release | Tier C |
| Older Adults (55+) | 0.5 - 2 mg | 1-2 hours before bed | Extended release (Circadin-type) | Tier A |
MIT research (Zhdanova et al., 2001) demonstrated that physiological doses (0.3mg) are as effective as pharmacological doses (3mg) for reducing sleep onset latency, without next-morning grogginess. Higher doses do not improve efficacy and may cause receptor desensitization. Start low.
Extended-release formulations maintain melatonin levels throughout the night, mimicking the natural secretion profile (which sustains elevated levels for 8-10 hours). Particularly useful for individuals over 55, whose endogenous melatonin production declines significantly. Circadin (2mg prolonged release) is the only melatonin formulation approved as a medicine in the EU.
Take melatonin at the bedtime of your destination time zone, starting the evening of arrival. For eastward travel (phase advance needed), you can begin 2-3 days before departure, taking 0.5mg 5 hours before your current bedtime and shifting 30 min earlier each day. The Cochrane Review (Herxheimer & Petrie, 2002) confirmed melatonin's efficacy for jet lag across 10 randomized trials.
Westward travel is generally easier (aligns with natural >24h drift), so melatonin supplementation is less critical. If used, take a low dose only if you wake too early in the new time zone. The primary strategy for westward adjustment is bright light exposure in the evening at the destination, not melatonin.
Shift workers sleeping during daylight hours have suppressed endogenous melatonin. Exogenous melatonin combined with complete darkness (blackout curtains, sleep mask) improves both sleep onset latency and total sleep time. Extended-release formulations are preferred because daytime sleep architecture needs sustained melatonin support against the alerting signal of the SCN, which is entrained to daylight.
This is the most misunderstood melatonin protocol. For DSPS, melatonin must be taken well BEFORE the desired bedtime — at the advance portion of the melatonin phase-response curve. Taking it at bedtime in DSPS is too late to shift the clock. Combined with morning bright light therapy, this protocol can advance the circadian phase by 1-2 hours over 2-4 weeks. Based on the work of Lewy et al. (1998).
Higher doses are used in clinical trials investigating melatonin's antioxidant, neuroprotective, and anti-inflammatory properties. At these doses, melatonin acts as a direct free radical scavenger and upregulates endogenous antioxidant enzymes (SOD, GPx, catalase). However, these doses exceed the physiological range and should be discussed with a physician. Research is promising but ongoing.
Melatonin production declines significantly with age — pineal calcification reduces output by 50-80% in adults over 60. The European Medicines Agency approved prolonged-release melatonin (Circadin) specifically for adults over 55 with primary insomnia. Extended-release formulations better replicate the youthful secretion pattern that aging pineal glands can no longer produce.
Always consult your physician before starting any supplement regimen. Melatonin dosing should be individualized based on age, indication, and concurrent medications.
Delivery Methods
The delivery method matters as much as the dose. Different forms suit different sleep problems.
Onset
20-40 minutes
Duration
3-5 hours
Bioavailability
~15% (significant first-pass metabolism)
Best For
Sleep onset difficulty, jet lag, DSPS phase-shifting
Most common form. Cheap and widely available. Peak plasma levels in 20-60 min.
Onset
10-20 minutes
Duration
3-4 hours
Bioavailability
~25-30% (bypasses first-pass metabolism)
Best For
Rapid sleep onset, acute use, travelers
Absorbs through oral mucosa directly into bloodstream. Faster onset, slightly higher bioavailability. Dissolve fully under tongue.
Onset
30-60 minutes
Duration
6-8 hours
Bioavailability
~15% (standard oral route)
Best For
Sleep maintenance, night waking, older adults (55+)
Mimics the natural melatonin secretion profile. Maintains plasma levels throughout the night. Circadin is the reference ER formulation.
Onset
15-30 minutes
Duration
3-5 hours
Bioavailability
~15-20%
Best For
Dose precision (micro-dosing 0.1-0.3mg), children (under medical supervision)
Allows precise dose control. Useful for the 'less is more' approach. Some sublingual absorption if held in mouth.
Onset
60-90 minutes
Duration
7-8 hours
Bioavailability
~65-80% (bypasses GI tract entirely)
Best For
Night-shift workers, long-haul travel, sustained delivery
Highest bioavailability of any form. Slow, steady release mimics endogenous profile. Still emerging in consumer market.
Onset
5-15 minutes
Duration
2-4 hours
Bioavailability
~70-80%
Best For
Acute sleep onset, emergency use (e.g., jet lag on arrival)
Very rapid absorption through nasal mucosa. High bioavailability. Less widely available. Short duration limits usefulness for maintenance.
Optimize Naturally
Before reaching for a pill, optimize the behavioral and environmental factors that drive endogenous melatonin synthesis. These are more impactful than any supplement.
Bright light (10,000+ lux) in the first 30-60 minutes after waking suppresses morning melatonin, triggers cortisol release, and — critically — sets the 14-16 hour countdown to evening dim light melatonin onset (DLMO). Without strong morning light input, the SCN cannot accurately time melatonin release. This is the single most powerful behavioral lever for healthy melatonin production.
Protocol
Get outside within 30 min of waking. 10-20 min of direct sunlight (no sunglasses). 20-30 min on overcast days. Use a 10,000 lux light therapy box if sunrise is after your wake time.
Duffy & Czeisler, Journal of Biological Rhythms, 2009
Melanopsin-containing retinal ganglion cells (ipRGCs) are maximally sensitive to blue and green wavelengths (460-530nm). Even moderate indoor lighting (200-500 lux) after sunset can suppress melatonin onset by 50-90% and delay DLMO by 60-90 minutes. The solution: transition to dim, warm-toned lighting (amber/red, <50 lux) 2-3 hours before bed. This allows the natural melatonin surge to proceed unimpeded.
Protocol
Dim overhead lights after sunset. Use amber/red bulbs or salt lamps. Wear blue-light blocking glasses after 8 PM. Screens at minimum brightness with max warm shift. No overhead fluorescent lighting.
Gooley et al., Journal of Clinical Endocrinology & Metabolism, 2011
Montmorency tart cherries contain a small amount of melatonin (13.5ng/g) and are rich in tryptophan and procyanidins (which inhibit the enzyme indoleamine 2,3-dioxygenase, shunting more tryptophan toward serotonin/melatonin synthesis rather than the kynurenine pathway). Two randomized trials (Howatson et al., 2012; Pigeon et al., 2010) found that tart cherry juice concentrate increased sleep time by 25-84 minutes and improved sleep efficiency.
Protocol
30mL (1 oz) tart cherry concentrate in water, twice daily — once in the morning and once 1-2 hours before bed. Use concentrate (not juice cocktail with added sugar). Expect effects after 5-7 days of consistent use.
Howatson et al., European Journal of Nutrition, 2012
Dietary tryptophan is the raw material for melatonin synthesis. Consuming tryptophan-rich foods at dinner (3-4 hours before bed) with a moderate carbohydrate load increases brain tryptophan availability: the carbohydrates trigger insulin, which drives competing BCAAs into muscle and clears the blood-brain barrier for tryptophan. This is the biochemical basis for the 'turkey makes you sleepy' phenomenon — though it is the tryptophan-carbohydrate combination, not turkey alone.
Protocol
Dinner should include tryptophan-rich protein (turkey, chicken, eggs, fish, dairy, pumpkin seeds) combined with complex carbohydrates (sweet potato, rice, oats). Avoid high-protein meals without carbs at dinner — this increases BCAA competition and may reduce brain tryptophan uptake.
Peuhkuri et al., Nutrition Research, 2012
Core body temperature drop is both a trigger for and a consequence of melatonin release. Melatonin promotes vasodilation in the extremities (hands, feet), which radiates heat outward and drops core temperature. A cool bedroom (60-67F / 15.5-19.5C) facilitates this process. Conversely, a warm bath 1-2 hours before bed paradoxically accelerates cooling by promoting vasodilation followed by rapid heat dissipation — the post-bath temperature drop can advance melatonin-associated sleep onset by 36%.
Protocol
Set bedroom to 60-67F. Optional: take a warm bath or shower 1-2 hours before bed. Use breathable bedding. Keep feet slightly exposed or use thin socks to promote distal vasodilation.
Haghayegh et al., Sleep Medicine Reviews, 2019
The SCN master clock entrains to habitual timing cues. A consistent wake time (including weekends) is the single most important anchor for reliable melatonin onset timing. Social jet lag — the discrepancy between weekday and weekend sleep timing — shifts DLMO by 30-90 minutes and fragments the melatonin secretion profile. Even a 1-hour weekend sleep-in delays melatonin onset the following evening.
Protocol
Fixed wake time 7 days per week (max 30 min variation). Fixed bedtime within a 30 min window. No 'catching up' on weekends — use short naps (20 min before 2 PM) instead.
Wittmann et al., Chronobiology International, 2006
Caffeine blocks adenosine receptors, which indirectly suppresses melatonin release by preventing the adenosine-driven activation of pineal melatonin synthesis pathways. A study by Burke et al. (2015) showed that a double espresso consumed 3 hours before bed delayed DLMO by approximately 40 minutes and reduced melatonin amplitude. Caffeine's half-life of 5-6 hours means that afternoon coffee directly impacts nighttime melatonin production.
Protocol
No caffeine after noon (or at least 8-10 hours before bedtime). Cap total daily intake at 200-400mg. Cycle off completely for 5-7 days every 8-12 weeks to reset adenosine receptor sensitivity.
Burke et al., Science Translational Medicine, 2015
Magnesium is a cofactor in the enzymatic conversion of tryptophan to serotonin (via tryptophan hydroxylase) and supports GABA receptor function, which facilitates the parasympathetic state necessary for melatonin release. Over 50% of adults are magnesium-deficient due to soil depletion and processed food diets. Supplementation (glycinate or threonate forms) has been shown to improve sleep quality, increase melatonin levels, and reduce cortisol — the hormone that directly antagonizes melatonin.
Protocol
200-400mg magnesium glycinate or L-threonate, taken 30-60 minutes before bed. Glycinate is preferred for sleep; L-threonate (Magtein) for cognitive benefits. Topical magnesium (Epsom salt baths, magnesium oil) is an additional route.
Abbasi et al., Journal of Research in Medical Sciences, 2012
More Than a Sleep Hormone
Melatonin's non-sleep functions are arguably as important as its role in circadian regulation. Research is rapidly expanding our understanding of this remarkable molecule.
Melatonin is one of the most potent endogenous antioxidants. Unlike most antioxidants, which neutralize one reactive oxygen species (ROS) and are then spent, melatonin undergoes a cascade reaction: each melatonin molecule can scavenge up to 10 ROS through its metabolites (AFMK, AMK). Melatonin also upregulates endogenous antioxidant enzymes — superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase — while downregulating pro-oxidant enzymes (nitric oxide synthase). It crosses all biological membranes, providing antioxidant protection in every cellular compartment, including mitochondria.
Reiter et al., Annals of the New York Academy of Sciences, 2002
Melatonin is an immunomodulator — it enhances immune function when the system is suppressed and attenuates it when overactive. Melatonin stimulates the production of natural killer (NK) cells, T-helper cells, and immunoglobulins via MT1 and nuclear ROR receptors on immune cells. It also reduces pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1-beta) in chronic inflammatory states. This dual role — immune-enhancing and anti-inflammatory — makes it relevant to both infectious disease defense and autoimmune conditions. Sleep deprivation suppresses melatonin and impairs immune function simultaneously.
Carrillo-Vico et al., International Journal of Molecular Sciences, 2013
Melatonin demonstrates oncostatic (tumor-inhibiting) properties across multiple cancer types in laboratory and epidemiological studies. Mechanisms include: direct cytotoxic effects on cancer cells, inhibition of tumor angiogenesis (new blood vessel formation), enhancement of DNA repair, and suppression of telomerase activity. The WHO classified shift work as a probable carcinogen (Group 2A) in part because chronic melatonin suppression from nighttime light exposure is associated with increased breast and prostate cancer risk. Harvard Nurses' Health Study data showed that women working rotating night shifts for 30+ years had a 36% increased risk of breast cancer.
Blask et al., Cancer Research, 2005; Schernhammer et al., JNCI, 2001
Melatonin protects neurons through multiple mechanisms: direct antioxidant scavenging of ROS and reactive nitrogen species in the brain, reduction of neuroinflammation, support of mitochondrial function in neurons, and enhancement of the glymphatic system (the brain's waste clearance pathway that is most active during sleep). Declining melatonin with age correlates with increased amyloid-beta accumulation — a hallmark of Alzheimer's disease. Early research suggests melatonin supplementation may slow cognitive decline in mild cognitive impairment (MCI), though large-scale trials are ongoing.
Pappolla et al., Journal of Pineal Research, 2000; Cardinali et al., 2012
The gut produces 400 times more melatonin than the pineal gland. Gut melatonin operates independently of the photoperiod and is released in response to food intake. It protects the gastrointestinal mucosa, reduces stomach acid secretion, increases bicarbonate production, and stimulates the immune system of the gut (GALT). Melatonin has been studied as an adjunct treatment for GERD, IBS, and ulcerative colitis, with promising results in reducing symptoms and mucosal inflammation.
Chen et al., Journal of Pineal Research, 2011
MT2 receptors on osteoblasts (bone-building cells) mediate melatonin's effects on bone health. Melatonin promotes osteoblast differentiation and proliferation while inhibiting osteoclast (bone-resorbing cell) activity. The age-related decline in melatonin correlates with the onset of osteoporosis, particularly in postmenopausal women. A 2014 study (Kotlarczyk et al.) found that melatonin supplementation (3mg nightly) in perimenopausal women improved bone mineral density markers over 6 months.
Kotlarczyk et al., Journal of Pineal Research, 2012
Across the Lifespan
Melatonin production peaks in childhood and declines progressively — understanding this trajectory informs supplementation decisions at every stage of life.
| Age Range | Production Level | Notes |
|---|---|---|
| Newborn (0-3 months) | Very low (maternal melatonin via breast milk) | Infants rely on maternal melatonin transferred through breast milk. Circadian rhythm not yet established. This is why newborns have no day/night distinction. |
| Child (1-5 years) | Peak lifetime production | Highest melatonin levels of any age group. The pineal gland is relatively large for body size and fully functional. Children have the strongest circadian rhythms. |
| Adolescent (12-18) | Begins to decline; phase delay | Puberty-related hormonal changes cause a 1-3 hour circadian delay — melatonin onset shifts later. This is the biological basis for teenage night-owl behavior, not laziness. School start times before 8:30 AM work against adolescent biology. |
| Young Adult (20-35) | Stable but declining from childhood peak | Peak nocturnal melatonin levels typically 60-200 pg/mL. Circadian amplitude is strong in healthy individuals maintaining good light hygiene. |
| Middle Age (40-55) | Noticeable decline (30-50% from peak) | Pineal calcification begins to accelerate. Sleep quality changes become apparent: lighter sleep, more night waking, earlier waking. Perimenopause further disrupts melatonin in women. |
| Older Adult (55-70) | Significant decline (50-70% from peak) | Nocturnal melatonin often <30 pg/mL. Circadian amplitude flattens. This is the demographic for which extended-release melatonin supplementation (Circadin) is approved in the EU. |
| Elderly (70+) | Severely reduced (70-80%+ decline) | Some elderly individuals produce barely detectable melatonin. Pineal calcification is extensive. Circadian rhythm fragmentation correlates with cognitive decline, sundowning behavior in dementia, and increased fall risk from night waking. |
Myth vs. Reality
Melatonin is surrounded by misinformation. Here is what the evidence actually says.
Reality: Melatonin does not create physical dependence or withdrawal symptoms. Unlike benzodiazepines, Z-drugs (zolpidem), or alcohol, melatonin does not alter GABA receptor expression or create tolerance through receptor downregulation at physiological doses (0.3-1mg). You can stop melatonin at any time without rebound insomnia. However, if the underlying cause of poor sleep (light exposure, irregular schedule, stress) is not addressed, sleep quality will return to baseline upon discontinuation — which may feel like 'dependency' but is not.
Reality: The opposite is often true. MIT research demonstrated that 0.3mg (300 micrograms) was equally or more effective than 3mg for improving sleep onset latency. Higher doses (5-10mg) flood receptors far beyond physiological levels, potentially causing next-morning grogginess, vivid dreams, headaches, and paradoxically reduced sleep quality. Many over-the-counter melatonin products contain 5-10mg — 10-30 times the physiologically effective dose. Start with 0.3-0.5mg and increase only if needed.
Reality: Sleep induction is just one of melatonin's many functions. It is a potent antioxidant (scavenging up to 10 ROS per molecule), an immunomodulator, a circadian phase-shifter, a neuroprotectant, a bone metabolism regulator, a gastrointestinal protectant, and an oncostatic molecule. The gut produces 400x more melatonin than the pineal gland for local protective functions. Research is actively exploring melatonin's role in neurodegeneration, cancer, metabolic syndrome, and cardiovascular disease.
Reality: At physiological doses (0.3-1mg), exogenous melatonin does not suppress endogenous production. The pineal gland's AANAT enzyme activity is controlled by the SCN's light/dark signal, not by circulating melatonin levels. Studies of long-term melatonin use (up to 4 years in European trials) show no evidence of reduced endogenous production upon discontinuation. At supraphysiological doses (10mg+), there is theoretical concern about MT1/MT2 receptor desensitization, but this has not been conclusively demonstrated in human studies.
Reality: Melatonin has an excellent safety profile. The European Medicines Agency approved prolonged-release melatonin (Circadin) for up to 13 weeks, with extension studies showing safety up to 1 year. In the US, melatonin has been available as a supplement since 1994 with no significant adverse event signals. The most common side effects at therapeutic doses are mild: drowsiness (intended), vivid dreams, mild headache. Serious adverse effects are rare and typically associated with doses >10mg or drug interactions (warfarin, immunosuppressants, diabetes medications).
Reality: For circadian phase-shifting (jet lag, DSPS), melatonin requires consistent use for 3-7 days to produce meaningful clock shifts. For sleep onset, a single dose can reduce latency on the first night, but the effect strengthens with consistent timing over several days as the exogenous melatonin signal reinforces the endogenous circadian rhythm. Setting expectations correctly prevents premature discontinuation.
CryoCove Integration
Every CryoCove pillar influences melatonin production and timing. Here is how to synchronize them for optimal circadian function.
Morning cold exposure (cold plunge, cold shower) triggers a norepinephrine and cortisol spike that powerfully suppresses residual morning melatonin, sharpening the cortisol-melatonin contrast that drives circadian amplitude. The larger the morning cortisol peak, the stronger the evening melatonin surge. Avoid cold exposure within 2 hours of bedtime — the post-cold rebound warming can delay melatonin-mediated sleep onset.
Evening sauna (1-2 hours before bed) raises core body temperature, and the subsequent cooling mimics and amplifies the natural temperature drop that accompanies melatonin release. The post-sauna cooling effect reduces sleep onset latency by up to 36%. Heat stress also increases deep (slow-wave) sleep, during which melatonin's restorative functions are most active.
Evening calming breathwork (4-7-8 breathing, coherent breathing at 5-6 breaths per minute, physiological sighs) activates the parasympathetic nervous system, reducing sympathetic tone that would otherwise suppress pineal melatonin release. The vagus nerve directly modulates SCN output. Stimulating breathwork (Wim Hof, Tummo) should be reserved for mornings, as the catecholamine release can suppress melatonin.
Regular exercise increases nocturnal melatonin amplitude. A 2019 meta-analysis (Buxton et al.) found that moderate aerobic exercise increased melatonin levels by 13-73%, with the greatest benefit from consistent exercise at the same time daily. Timing matters: morning and afternoon exercise enhance melatonin production; intense exercise within 2-3 hours of bedtime can delay melatonin onset via elevated cortisol and core temperature.
Melatonin IS the Rest pillar's primary hormonal mediator. It initiates sleep onset, supports sleep maintenance, enhances deep sleep percentage, and facilitates the glymphatic clearance that occurs during NREM sleep. A consistent sleep-wake schedule is the behavioral anchor that stabilizes melatonin timing. Every other pillar's melatonin-related protocol ultimately serves the goal of optimal sleep architecture.
Light is the master regulator of melatonin. Morning bright light (10,000+ lux) sets the 14-16 hour countdown to DLMO. Evening dim light (<50 lux, amber/red wavelengths) permits melatonin synthesis. Red light therapy (630-670nm) does not suppress melatonin and can be used at night. Blue-light blocking after sunset is the single most impactful behavioral change for melatonin optimization.
Dehydration impairs enzymatic processes throughout the body, including the melatonin biosynthesis pathway. Front-load hydration during daylight hours and taper 2-3 hours before bed to minimize nocturia (nighttime urination), which fragments sleep and disrupts the sustained melatonin plateau needed for restorative sleep. Morning electrolytes (sodium, potassium, magnesium) support the cortisol awakening response that establishes the cortisol-melatonin rhythm.
Nutrition provides every building block for melatonin synthesis: tryptophan (precursor), vitamin B6 (cofactor for decarboxylase), folate and B12 (methylation support), magnesium (cofactor for TPH), zinc (supports AANAT), and SAMe (methyl donor for HIOMT). Tart cherry juice, walnuts, and pistachios are direct dietary melatonin sources. Meal timing aligned with daylight hours reinforces peripheral clock synchronization with the SCN's melatonin signal.
Chronic psychological stress elevates evening cortisol, which directly suppresses pineal melatonin synthesis (cortisol and melatonin are antagonistic hormones). Evening meditation, gratitude journaling, and body scan relaxation reduce cortisol and sympathetic nervous system activation, creating the neurochemical environment necessary for melatonin release. Yoga Nidra (non-sleep deep rest) has been shown to increase melatonin levels by 98% in a single session (Tooley et al., 2000).
Who Should Be Careful
Melatonin is generally safe, but specific populations require additional caution and physician oversight.
Children naturally produce the highest melatonin levels of any age group. Routine melatonin supplementation in healthy children is generally unnecessary and not recommended. However, melatonin is studied and used (under medical supervision) in children with autism spectrum disorder (ASD), ADHD, and neurodevelopmental conditions that impair endogenous melatonin production or circadian entrainment. Doses of 0.5-3mg are typical in pediatric research. The European MHRA and American Academy of Sleep Medicine recommend physician oversight for all pediatric melatonin use.
Dosing
0.5 - 1mg (physician-supervised only)
Pubertal phase delay shifts melatonin onset 1-3 hours later, making early school start times biologically misaligned. Low-dose melatonin (0.3-0.5mg) taken 3-5 hours before the desired bedtime can advance the clock and improve school-night sleep without suppressing endogenous production. Morning bright light therapy is equally or more important. Combining both is the gold standard for adolescent delayed sleep phase.
Dosing
0.3 - 0.5mg (5 hours before desired bedtime)
Melatonin crosses the placenta and is present in breast milk (with a nocturnal peak that helps entrain the infant's developing circadian system). While melatonin supplementation is sometimes used in IVF and reproductive medicine, routine supplementation during pregnancy is not well studied and should only be used under direct medical supervision. The most important strategy is light hygiene: maintain strong circadian signals through morning light and evening darkness.
Dosing
Consult physician (avoid supplementation unless directed)
Melatonin interacts with several medication classes: warfarin and other anticoagulants (melatonin may increase bleeding risk), immunosuppressants (melatonin enhances immune function), diabetes medications (melatonin affects glucose metabolism via MT2 receptors), antihypertensives (melatonin lowers blood pressure), fluvoxamine (SSRI that dramatically increases melatonin levels by inhibiting CYP1A2 metabolism). Always consult your prescribing physician before adding melatonin to any medication regimen.
Dosing
Physician-directed only
Common Questions
Research from MIT (Zhdanova et al., 2001) demonstrated that physiological doses of 0.3mg are as effective as pharmacological doses of 3mg for reducing sleep onset latency — and with fewer side effects. The 'less is more' principle applies strongly to melatonin: start with 0.3-0.5mg of immediate-release melatonin taken 30-60 minutes before desired bedtime. If sleep onset is not improved after 5-7 nights, increase to 1mg. Most adults do not need more than 1-2mg. The 5-10mg tablets commonly sold in stores are supraphysiological and can cause next-morning drowsiness, vivid dreams, and paradoxically lighter sleep.
It depends on your goal. For general sleep onset improvement: take immediate-release melatonin 30-60 minutes before your desired bedtime. For Delayed Sleep Phase Syndrome (DSPS): take melatonin 5-7 hours before your current sleep onset time — this targets the phase-advance portion of the melatonin response curve and is far more effective than bedtime dosing for shifting the clock. For jet lag: take melatonin at the target destination bedtime starting the evening of arrival. The common mistake is taking melatonin too late — it needs time to signal the SCN before your body expects to sleep.
Melatonin should not be given to healthy children without medical supervision. Children naturally produce the highest melatonin levels of any age group, and supplementation is typically unnecessary. However, melatonin is used under physician guidance in children with autism spectrum disorder (ASD), ADHD, neurodevelopmental conditions, and specific sleep disorders. Doses of 0.5-1mg are typical in pediatric studies. The American Academy of Sleep Medicine recommends that parents first address behavioral sleep factors (screen time, consistent bedtime routine, light hygiene) before considering melatonin. Never give children adult-dose melatonin (3-10mg).
No. Melatonin does not create physical dependence or withdrawal symptoms. It does not work through GABA receptors (like benzodiazepines) or histamine pathways (like diphenhydramine). The pineal gland's melatonin production is controlled by the SCN's response to light, not by circulating melatonin levels. Long-term studies (up to 4 years) show no evidence of reduced endogenous production after stopping supplementation. However, if the underlying cause of poor sleep (evening light exposure, irregular schedule, stress) is not addressed, sleep quality will return to its prior state when you stop taking melatonin. This is not dependency — it is the unresolved root cause reasserting itself.
At physiological doses (0.3-1mg), nightly melatonin use appears safe based on available evidence. The EU-approved medication Circadin (2mg prolonged-release) is studied for continuous use up to 13 weeks with extension data to 1 year. Many sleep medicine physicians recommend nightly use for specific populations (older adults with documented low melatonin, shift workers, those with circadian rhythm disorders). However, the optimal approach is to fix the behavioral foundations first — morning light, evening darkness, consistent schedule, cool bedroom — and use melatonin as a bridge while establishing these habits, not as a permanent substitute for good circadian hygiene.
Two mechanisms explain this. First, excessive doses (3-10mg) can alter sleep architecture by increasing REM sleep proportion and REM intensity — since vivid dreaming occurs in REM, more intense REM means more vivid dreams. Second, if melatonin helps you sleep longer or deeper, you may simply remember more of the dreams you were already having (dream recall is higher when you wake from REM). The solution: reduce your dose. Switching from 3-5mg to 0.3-0.5mg typically resolves vivid dreams while maintaining the sleep onset benefit. If vivid dreams persist at 0.3mg, you may be a 'melatonin-sensitive' individual and should focus on natural production boosters instead.
DLMO is the time at which your body begins secreting melatonin in the evening under dim light conditions (<30 lux). It typically occurs 2-3 hours before habitual sleep onset and is considered the most reliable biomarker of circadian phase in sleep medicine research. DLMO timing determines when your body is biologically ready to sleep. If you try to sleep before DLMO, you are fighting your biology. Measuring DLMO requires collecting saliva samples every 30 minutes in dim light conditions — this is typically done in a sleep lab or research setting. Clinically, DLMO can be estimated: if your habitual sleep onset is 11 PM, your DLMO is approximately 8-9 PM.
Melatonin production declines significantly across the lifespan. Children produce the highest levels (peak nocturnal concentrations of 200+ pg/mL). By age 40-55, production has declined 30-50% from its childhood peak. By age 60-70, many individuals have lost 50-70% of their peak production. By 70+, some elderly individuals produce barely detectable amounts. The primary mechanism is pineal calcification — calcium deposits accumulate in the pineal gland with age, reducing the tissue available for melatonin synthesis. This decline correlates with the well-documented deterioration of sleep quality with aging: lighter sleep, more night waking, earlier morning waking, and reduced slow-wave sleep.
Yes. Key interactions include: warfarin and anticoagulants (melatonin may increase bleeding risk), immunosuppressants like cyclosporine (melatonin stimulates immune function and could counteract immunosuppression), diabetes medications (melatonin affects glucose metabolism through MT2 receptors), antihypertensives (additive blood pressure lowering), fluvoxamine (this SSRI inhibits CYP1A2, the primary enzyme that metabolizes melatonin, causing plasma melatonin levels to increase dramatically — by up to 12-fold), and sedative medications (additive drowsiness). Always inform your physician and pharmacist if you are using melatonin alongside any prescription medications.
Synthetic melatonin is chemically identical to the melatonin produced by your pineal gland — it is the same molecule (N-acetyl-5-methoxytryptamine). Always choose synthetic melatonin over 'natural' melatonin derived from animal pineal glands, which carries a theoretical risk of prion contamination and viral transmission. The vast majority of melatonin supplements on the market are synthetic. However, quality control is a real concern: a 2017 study by Erland & Saxena analyzed 31 melatonin supplements and found that actual melatonin content varied from -83% to +478% of what was stated on the label. Choose USP-verified or third-party tested brands.
Sleep Optimization
Melatonin is just one piece of the sleep puzzle. Master sleep architecture, temperature, and the full protocol for deep, restorative sleep.
Circadian Science
The SCN master clock, zeitgebers, ideal circadian day timeline, jet lag protocols, and shift work strategies.
Light Therapy
Light is the master regulator of melatonin. Morning sunlight, evening darkness, and red light therapy protocols.
Environment
Temperature, darkness, sound, and air quality — optimize the physical space where melatonin does its work.
This guide gives you the science. A CryoCove coach gives you the personalization — analyzing your chronotype, light exposure, sleep data, stress load, and supplement stack to design a melatonin and circadian protocol optimized for YOUR biology and schedule.